← Back to pipeline

Ophthalmology

Ocular sustained-release implant

A small implant delivering a precisely metered dose to ocular tissue over months, reducing injection frequency.

Development stage

  1. Discovery
  2. Preclinical
  3. Clinical
  4. Regulatory review
  5. Marketed
Indication
Chronic posterior segment disease

About the programme

Ocular tissue tolerates very little: dosing precision and material biocompatibility decide the outcome.

Built on the same polymer science that governs our vascular coatings.